{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T18:02:23Z","timestamp":1786384943495,"version":"build-2736575974"},"reference-count":29,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2011,5,1]],"date-time":"2011-05-01T00:00:00Z","timestamp":1304208000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,5,1]],"date-time":"2011-05-01T00:00:00Z","timestamp":1304208000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100004312","name":"Eli Lilly and Company","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100004312","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Psychiatry Research"],"published-print":{"date-parts":[[2011,5]]},"DOI":"10.1016\/j.psychres.2010.10.020","type":"journal-article","created":{"date-parts":[[2010,11,21]],"date-time":"2010-11-21T04:11:43Z","timestamp":1290312703000},"page":"74-79","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["Association of DRD2 and ANKK1 polymorphisms with prolactin increase in olanzapine-treated women"],"prefix":"10.1016","volume":"187","author":[{"given":"John","family":"Houston","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sweta","family":"Dharia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey R.","family":"Bishop","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vicki L.","family":"Ellingrod","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bonnie","family":"Fijal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennie G.","family":"Jacobson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vicki P.","family":"Hoffmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.psychres.2010.10.020_bb0005","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1097\/FPC.0b013e3282f01aa3","article-title":"CYP2D6 and DRD2 genes differentially impact pharmacodynamic sensitivity and time course of prolactin response to perphenazine","volume":"17","author":"Aklillu","year":"2007","journal-title":"Pharmacogenetics and Genomics"},{"key":"10.1016\/j.psychres.2010.10.020_bb0010","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1089\/104454602760219126","article-title":"Correlation of antipsychotic and prolactin concentrations in children and adolescents acutely treated with haloperidol, clozapine, or olanzapine","volume":"12","author":"Alfaro","year":"2002","journal-title":"Journal of Child and Adolescent Psychopharmacology"},{"key":"10.1016\/j.psychres.2010.10.020_bb0015","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1093\/hmg\/6.4.577","article-title":"Functional polymorphism in the promoter region of the dopamine D2 receptor gene is associated with schizophrenia","volume":"6","author":"Arinami","year":"1997","journal-title":"Human Molecular Genetics"},{"key":"10.1016\/j.psychres.2010.10.020_bb0020","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1093\/bioinformatics\/bth457","article-title":"Haploview: analysis and visualization of LD and haplotype maps","volume":"21","author":"Barret","year":"2005","journal-title":"Bioinformatics"},{"key":"10.1016\/j.psychres.2010.10.020_bb0030","first-page":"996","article-title":"Osteopenia in women with hypothalamic amenorrhea: a prospective study","volume":"78","author":"Biller","year":"1991","journal-title":"Obstetrics and Gynecology"},{"key":"10.1016\/j.psychres.2010.10.020_bb0035","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.4088\/JCP.v67n0703","article-title":"A 7-week, randomized, double-blind trial of olanzapine\/fluoxetine combination versus lamotrigine in the treatment of bipolar I disorder","volume":"67","author":"Brown","year":"2006","journal-title":"The Journal of Clinical Psychiatry"},{"key":"10.1016\/j.psychres.2010.10.020_bb0040","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1097\/FPC.0b013e328329a60f","article-title":"Variants of the dopamine D2 receptor gene and risperidone-induced hyperlactinemia in children and adolescents","volume":"19","author":"Calarge","year":"2009","journal-title":"Pharmacogenetics and Genomics"},{"key":"10.1016\/j.psychres.2010.10.020_bb0045","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1093\/hmg\/ddg055","article-title":"Synonymous mutations in the human dopamine receptor D2 (DRD2) affect mRNA stability and synthesis of the receptor","volume":"12","author":"Duan","year":"2003","journal-title":"Human Molecular Genetics"},{"key":"10.1016\/j.psychres.2010.10.020_bb0050","doi-asserted-by":"crossref","first-page":"2225","DOI":"10.1126\/science.1069424","article-title":"The structure of haplotype blocks in the human genome","volume":"296","author":"Gabriel","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.psychres.2010.10.020_bb0055","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1097\/00006842-199509000-00011","article-title":"Decreased bone mineral density in medicated psychiatric patients","volume":"57","author":"Halbreich","year":"1995","journal-title":"Psychosomatic Medicine"},{"key":"10.1016\/j.psychres.2010.10.020_bb0060","series-title":"Statistical Methods for Meta-Analysis","author":"Hedges","year":"1985"},{"key":"10.1016\/j.psychres.2010.10.020_bb0065","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.psychres.2009.06.014","article-title":"Genetic associations of prolactin increase in olanzapine\/fluoxetine combination-treated patients","volume":"175","author":"Houston","year":"2010","journal-title":"Psychiatry Research"},{"key":"10.1016\/j.psychres.2010.10.020_bb0070","first-page":"179","article-title":"Automated genotyping using the DNA MassArray technology","volume":"187","author":"Jurinke","year":"2002","journal-title":"Methods in Molecular Biology"},{"key":"10.1016\/j.psychres.2010.10.020_bb0075","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1016\/j.euroneuro.2008.07.010","article-title":"TaqA polymorphism in the dopamine D2 receptor gene as a predictor of clinical response to aripiprazole","volume":"18","author":"Kwon","year":"2008","journal-title":"European Neuropsychopharmacology"},{"key":"10.1016\/j.psychres.2010.10.020_bb0080","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1192\/bjp.184.6.503","article-title":"Effects of long-term prolactin-raising antipsychotic medication on bone mineral density in patients with schizophrenia","volume":"184","author":"Meaney","year":"2004","journal-title":"The British Journal of Psychiatry"},{"key":"10.1016\/j.psychres.2010.10.020_bb0085","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1007\/s002139900364","article-title":"Prolactin response to nemonapride, a selective antagonist of D2 like dopamine receptors, in schizophrenic patients in relation to Taq1A polymorphism of DRD2 gene","volume":"149","author":"Mihara","year":"2000","journal-title":"Psychopharmacology (Berlin)"},{"key":"10.1016\/j.psychres.2010.10.020_bb0090","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1002\/1096-8628(20001009)96:5<622::AID-AJMG7>3.0.CO;2-5","article-title":"Haplotypes at the DRD2 locus and severe alcoholism","volume":"96","author":"Noble","year":"2000","journal-title":"American Journal of Medical Genetics"},{"issue":"Suppl","key":"10.1016\/j.psychres.2010.10.020_bb0095","doi-asserted-by":"crossref","first-page":"S67","DOI":"10.1016\/S0920-9964(98)00158-3","article-title":"Prolactin and antipsychotic medications: mechanism of action","volume":"35","author":"Petty","year":"1999","journal-title":"Schizophrenia Research"},{"key":"10.1016\/j.psychres.2010.10.020_bb0100","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1016\/j.pnpbp.2006.05.011","article-title":"Gender differences in prolactin elevation induced by olanzapine in Japanese drug-na\u00efve schizophrenic patients","volume":"30","author":"Sawamura","year":"2006","journal-title":"Progress in Neuropsychopharmacology & Biological Psychiatry"},{"key":"10.1016\/j.psychres.2010.10.020_bb0105","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1192\/bjp.bp.107.037903","article-title":"Olanzapine for the treatment of borderline personality disorder: variable dose 12-week randomized double-blind placebo controlled study","volume":"193","author":"Schulz","year":"2008","journal-title":"The British Journal of Psychiatry"},{"key":"10.1016\/j.psychres.2010.10.020_bb0110","doi-asserted-by":"crossref","first-page":"224","DOI":"10.4088\/JCP.v68n0207","article-title":"A randomized, double-blind comparison of olanzapine\/fluoxetine combination, olanzapine, and fluoxetine in treatment-resistant major depressive disorder","volume":"68","author":"Thase","year":"2007","journal-title":"The Journal of Clinical Psychiatry"},{"key":"10.1016\/j.psychres.2010.10.020_bb0115","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1097\/00008571-199712000-00006","article-title":"D2 dopamine receptor gene (DRD2) Taq1 A polymorphism: reduced dopamine D2 receptor binding in the human striatum associated with the A1 allele","volume":"7","author":"Thompson","year":"1997","journal-title":"Pharmacogenetics"},{"key":"10.1016\/j.psychres.2010.10.020_bb0120","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.4088\/JCP.v69n1113","article-title":"Olanzapine versus divalproex versus placebo in the treatment of mild to moderate mania: a randomized, 12-week, double-blind study","volume":"69","author":"Tohen","year":"2008","journal-title":"The Journal of Clinical Psychiatry"},{"key":"10.1016\/j.psychres.2010.10.020_bb0125","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1192\/bjp.182.3.199","article-title":"Antipsychotic-induced hyperprolactinaemia in women: pathophysiology, severity and consequences","volume":"182","author":"Wieck","year":"2003","journal-title":"The British Journal of Psychiatry"},{"key":"10.1016\/j.psychres.2010.10.020_bb0130","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1016\/j.pnpbp.2008.05.006","article-title":"Association between dopamine-related polymorphisms and plasma concentrations of prolactin during risperidone treatment in schizophrenic patients","volume":"32","author":"Yasui-Furukori","year":"2008","journal-title":"Progress in Neuropsychopharmacololgy and Biological Psychatry"},{"key":"10.1016\/j.psychres.2010.10.020_bb0135","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1192\/bjp.185.2.147","article-title":"Prolactin levels in antipsychotic treatment of patients with schizophrenia carrying the DRD2*A1 allele","volume":"185","author":"Young","year":"2004","journal-title":"The British Journal of Psychiatry"},{"key":"10.1016\/j.psychres.2010.10.020_bb0140","first-page":"248","article-title":"Genetic study of eight AKT1 gene polymorphisms and their interaction with DRD2 gene polymorphisms in tardive dyskinesia","volume":"2004","author":"Zai","year":"2004","journal-title":"Schizophrenia Research"},{"issue":"Suppl 1","key":"10.1016\/j.psychres.2010.10.020_bb0145","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.eurpsy.2007.01.565","article-title":"A dose comparison of olanzapine for the treatment of borderline personality disorder: a 12-week randomized, double-blind, placebo-controlled study","volume":"22","author":"Zanarini","year":"2007","journal-title":"European Psychiatry"},{"key":"10.1016\/j.psychres.2010.10.020_bb0150","doi-asserted-by":"crossref","first-page":"20552","DOI":"10.1073\/pnas.0707106104","article-title":"Polymorphisms in human dopamine D2 receptor gene affect gene expression, splicing, and neuronal activity during working memory","volume":"104","author":"Zhang","year":"2007","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"}],"container-title":["Psychiatry Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165178110006505?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165178110006505?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T05:20:09Z","timestamp":1759036809000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165178110006505"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,5]]},"references-count":29,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2011,5]]}},"alternative-id":["S0165178110006505"],"URL":"https:\/\/doi.org\/10.1016\/j.psychres.2010.10.020","relation":{},"ISSN":["0165-1781"],"issn-type":[{"value":"0165-1781","type":"print"}],"subject":[],"published":{"date-parts":[[2011,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Association of DRD2 and ANKK1 polymorphisms with prolactin increase in olanzapine-treated women","name":"articletitle","label":"Article Title"},{"value":"Psychiatry Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.psychres.2010.10.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}